These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1412676)

  • 1. Human immunodeficiency virus infection due to clotting factor concentrates: results of the Seroconversion Surveillance Project.
    Fricke W; Augustyniak L; Lawrence D; Brownstein A; Kramer A; Evatt B
    Transfusion; 1992 Oct; 32(8):707-9. PubMed ID: 1412676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-antibody seroconversions in Dutch haemophiliacs using heat-treated and non heat-treated coagulation factor concentrates.
    Wolfs TF; Breederveld C; Krone WJ; vd Hoek L; Bakker M; Smit L; Goudsmit J
    Thromb Haemost; 1988 Jun; 59(3):396-9. PubMed ID: 3142077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood safety monitoring among persons with bleeding disorders--United States, May 1998-June 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Jan; 51(51-52):1152-4. PubMed ID: 12553567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: frequent transmission by virally inactivated clotting factor concentrates.
    Sharp CP; Lail A; Donfield S; Gomperts ED; Simmonds P
    Transfusion; 2012 Jul; 52(7):1482-9. PubMed ID: 22043925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An association between clotting factor concentrates use and mortality in human immunodeficiency virus-infected hemophilic patients.
    Montoro JB; Oliveras J; Lorenzo JI; Tusell JM; Altisent C; Molina R; Ayestarán AI
    Blood; 1995 Sep; 86(6):2213-9. PubMed ID: 7662971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 infection incidence among persons with hemophilia in the United States and western Europe, 1978-1990. Multicenter Hemophilia Cohort Study.
    Kroner BL; Rosenberg PS; Aledort LM; Alvord WG; Goedert JJ
    J Acquir Immune Defic Syndr (1988); 1994 Mar; 7(3):279-86. PubMed ID: 8106967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission of human immunodeficiency virus type 1 by dry-heated clotting factor concentrates. Transfusion Safety Study Group.
    Dietrich SL; Mosley JW; Lusher JM; Hilgartner MW; Operskalski EA; Habel L; Aledort LM; Gjerset GF; Koerper MA; Lewis BH
    Vox Sang; 1990; 59(3):129-35. PubMed ID: 2124751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates.
    Kupfer B; Ruf T; Matz B; Nattermann J; Spengler U; Rockstroh JK; Brackmann HH; Blümel J; Tacke M; Kaiser R
    J Clin Virol; 2005 Sep; 34(1):42-7. PubMed ID: 16087123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological abnormalities in haemophiliacs.
    Watson HG; Ludlam CA
    Blood Rev; 1992 Mar; 6(1):26-33. PubMed ID: 1586776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of clotting factor concentrates on the immune system in individuals with hemophilia.
    Gomperts ED; de Biasi R; De Vreker R
    Transfus Med Rev; 1992 Jan; 6(1):44-54. PubMed ID: 1348008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral safety of coagulation factor concentrates: memoirs from an insider.
    Mannucci PM
    J Thromb Haemost; 2018 Apr; 16(4):630-633. PubMed ID: 29383815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in Leu 2+ Leu 7+ lymphocytes in HIV 1-seropositive patients with hemophilia repeatedly treated with clotting factor concentrates.
    Kaplan J; Sarnaik I; Lusher J
    Clin Immunol Immunopathol; 1988 Mar; 46(3):337-41. PubMed ID: 3257429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS and hemophilia: experience in the La Paz Hemophilia Center.
    Magallón Martínez M; Ortega F; Pinilla J
    Haemostasis; 1992; 22(5):281-92. PubMed ID: 1362177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of AIDS, AIDS related complex and HIV seropositivity in a large population of patients with congenital clotting disorders.
    Girolami A; Luzzatto G; Dal Bo Zanon R; Lazzaro AR; De Rossi A; Stocco D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):825-32. PubMed ID: 2467853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heated clotting factors and seroconversion for human immunodeficiency virus in three hemophilic patients.
    Mariani G; Ghirardini A; Mandelli F; Verani P; Buttó S; Rossi GB; Mannucci PM
    Ann Intern Med; 1987 Jul; 107(1):113. PubMed ID: 3473956
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of coagulation factor concentrates.
    Teitel JM
    Haemophilia; 1998 Jul; 4(4):393-401. PubMed ID: 9873760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of anti-human immunodeficiency virus types 1 and 2 seroconversion after the treatment of hemophilia A or von Willebrand's disease with pasteurized factor VIII concentrate.
    Schimpf K; Brackmann HH; Kreuz W; Kraus B; Haschke F; Schramm W; Moesseler J; Auerswald G; Sutor AH; Koehler K
    N Engl J Med; 1989 Oct; 321(17):1148-52. PubMed ID: 2507917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of HIV infection and AIDS in a cohort of Italian hemophiliacs.
    Sorice F; Ghirardini A; Martino P; Pasqualetti D; Annino L; Micozzi A; Cirelli A; Tamburrini E; Isacchi G; Buttò S
    Haematologica; 1989; 74(2):149-54. PubMed ID: 2568323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and interaction of human immunodeficiency virus and hepatitis B virus infections in Israeli hemophiliacs.
    Brenner B; Schwartz S; Ben-Porath E; Tatarsky I; Varon D; Martinowitz U
    Isr J Med Sci; 1991 Oct; 27(10):557-61. PubMed ID: 1955309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression to AIDS in relation to clinical factors and clotting product consumption. A 14-year follow-up of a cohort of 52 Dutch HIV-1-infected haemophilic patients.
    Roosendaal G; van der Schouw Y; Mauser-Bunschoten E; Borleffs J; van den Berg H
    Vox Sang; 1998; 75(4):261-6. PubMed ID: 9873260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.